The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir).

Enterome has secured $19m in new private funding to progress its EO2463 OncoMimics immunotherapy, targeting iNHL.

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

The future of US immunisation is up in the air as outspoken critics of vaccines populate an integral recommendation committee ...

BioNTech has agreed to acquire CureVac for approximately $1.25bn, as the former amps up its strategy to offer cancer ...

The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...

The FDA has approved Capsida Biotherapeutics' investigational new drug (IND) application for CAP-003 to treat Parkinson’s ...

GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will change the treatment paradigm.

Geopolitical disturbances across the supply chain are further complicating the complex pharma customs process.

SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

Antares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.

The UK’s National Health Service (NHS) is receiving a £29bn ($39.1bn) funding boost, reflecting a 3% annual rise on current ...